SCHEMBL7422965

SCHEMBL7422965

CC(C)C[C@H](N)C(O)[Si](C)(C)C(C)(C)C

nearest known ligand 0.38

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
ANPEP P15144 5/20 0.33
ALDH1A1 P00352 1/20 0.33
TSHR P16473 1/20 0.33
MAPK1 P28482 1/20 0.33
DNPEP Q9ULA0 1/20 0.33
SLC7A5 Q01650 1/20 0.31
LAP3 P28838 2/20 0.30
ERAP1 Q9NZ08 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27934672 0.75
SCHEMBL8486133 0.72
SCHEMBL8664070 0.69 ALDH1A1 (0.31) ALDH1A1
SCHEMBL2953547 0.69 TSHR (0.39) ANPEPALDH1A1TSHRMAPK1DNPEP
SCHEMBL23343276 0.66
SCHEMBL10580204 0.66
SCHEMBL20845811 0.66
SCHEMBL20763921 0.66
SCHEMBL4407497 0.66
SCHEMBL5740524 0.66

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6191277-B1 AND INTERMEDIATES THEREOF ATTACHED TO A SOLID PHASE SUPPORT, USEFUL FOR TREATMENT OF MALARIA AND ALZHEIMER'S DISEASE; INHIBITORY ACTIVITY AGAINST PLASMEPSIN AND CATHEPSIN D PHARMACOPEIA, INC. 2001-02-20 US disclosed
US-5986102-A ENZYME INHIBITORS OF ASPARTYL PROTEASES PHARMACOPEIA, INC. (US) 1999-11-16 US disclosed
WO-1999055687-A2 HYDROXYPROPYLAMIDE PEPTIDOMIMETICS AS INHIBITORS OF ASPARTYL PROTEASES PHARMACOPEIA, INC. (US) 1999-11-04 WO disclosed